[go: up one dir, main page]

PL323931A1 - Compositions of reversed emulsion of fluorine derivatives of hydrocarbons for use as drug delivering carriers - Google Patents

Compositions of reversed emulsion of fluorine derivatives of hydrocarbons for use as drug delivering carriers

Info

Publication number
PL323931A1
PL323931A1 PL96323931A PL32393196A PL323931A1 PL 323931 A1 PL323931 A1 PL 323931A1 PL 96323931 A PL96323931 A PL 96323931A PL 32393196 A PL32393196 A PL 32393196A PL 323931 A1 PL323931 A1 PL 323931A1
Authority
PL
Poland
Prior art keywords
hydrocarbons
compositions
drug delivering
fluorine derivatives
reversed emulsion
Prior art date
Application number
PL96323931A
Inventor
Thomas E Tarara
Jeffry G Weers
Leo A Trevino
Alexey Kabalnov
Luis A Dellamary
Gina M Hopper
Helen M Ranney
David H Klein
Timothy J Pelura
Original Assignee
Alliance Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Pharma filed Critical Alliance Pharma
Publication of PL323931A1 publication Critical patent/PL323931A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL96323931A 1995-06-07 1996-06-05 Compositions of reversed emulsion of fluorine derivatives of hydrocarbons for use as drug delivering carriers PL323931A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48761295A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
PL323931A1 true PL323931A1 (en) 1998-04-27

Family

ID=23936452

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96323931A PL323931A1 (en) 1995-06-07 1996-06-05 Compositions of reversed emulsion of fluorine derivatives of hydrocarbons for use as drug delivering carriers

Country Status (11)

Country Link
EP (1) EP0833608A2 (en)
JP (1) JPH11508237A (en)
KR (1) KR19990022354A (en)
CN (1) CN1195981A (en)
AU (1) AU704918B2 (en)
CA (1) CA2222063A1 (en)
HU (1) HUP9900879A2 (en)
IL (1) IL122249A0 (en)
NO (1) NO975321L (en)
PL (1) PL323931A1 (en)
WO (1) WO1996040057A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021541A2 (en) * 1997-10-24 1999-05-06 Alliance Pharmaceutical Corp. Amelioration of ischemic damage using synthetic oxygen carriers
WO1999024016A1 (en) * 1997-11-10 1999-05-20 Sonus Pharmaceuticals, Inc. Emulsions for aerosolization and drug delivery
US6127430A (en) * 1998-12-16 2000-10-03 3M Innovative Properties Company Microemulsions containing water and hydrofluroethers
US6159917A (en) * 1998-12-16 2000-12-12 3M Innovative Properties Company Dry cleaning compositions containing hydrofluoroether
US6312665B1 (en) * 1998-12-21 2001-11-06 Generex Pharmaceuticals Incorporated Aerosol formulations for buccal and pulmonary application
US7087215B2 (en) 1998-12-21 2006-08-08 Generex Pharmaceuticals Incorporated Methods of administering and enhancing absorption of pharmaceutical agents
EP1338272A1 (en) * 1998-12-21 2003-08-27 Generex Pharmaceuticals Inc. Aerosol formulations for buccal and pulmonary application comprising chenodeoxycholate or deoxycholate
US6271200B1 (en) 1998-12-21 2001-08-07 Generex Pharmaceuticals Inc. Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles
US6849263B2 (en) 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
US6294153B1 (en) 1998-12-21 2001-09-25 Generex Pharmaceuticals, Inc. Aerosol pharmaceutical formulation for pulmonary and nasal delivery
US6451286B1 (en) * 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US6375975B1 (en) * 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
US7357937B2 (en) * 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
GB0307403D0 (en) * 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
AU2003903296A0 (en) * 2003-06-30 2003-07-10 Raustech Pty Ltd Chemical compositions of matter
EP1815869A4 (en) * 2004-11-24 2011-04-06 Nanocarrier Co Ltd Method of changing morphology of block copolymer
EP3913375A1 (en) 2006-01-11 2021-11-24 Bio-Rad Laboratories, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
EP2530167A1 (en) 2006-05-11 2012-12-05 Raindance Technologies, Inc. Microfluidic Devices
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
FR2903602B1 (en) * 2006-07-12 2012-10-26 Seppic Sa INJECTABLE FORMULATION WITH PROLONGED RELEASE OF ACTIVE INGREDIENTS, PROCESS FOR PREPARING THE SAME
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
AU2009206391A1 (en) * 2008-01-22 2009-07-30 Board Of Regents, The University Of Texas System Volatile anesthetic compositions and methods of use
EP2123256A1 (en) 2008-05-19 2009-11-25 Ruhr-Universität Bochum Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
EP2315629B1 (en) 2008-07-18 2021-12-15 Bio-Rad Laboratories, Inc. Droplet libraries
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
EP4484577A3 (en) 2010-02-12 2025-03-26 Bio-Rad Laboratories, Inc. Digital analyte analysis
EP2587917A4 (en) * 2010-07-01 2015-05-06 Mtm Res Llc Anti-fibroblastic fluorochemical emulsion therapies
WO2012003457A1 (en) * 2010-07-01 2012-01-05 Mtm Research Llc Anti-fibroblastic fluorochemical emulsion therapies
CN103228283A (en) * 2010-11-29 2013-07-31 千寿制药株式会社 Oil-in-water emulsion composition containing difluprednate and tobramycin
EP3736281A1 (en) 2011-02-18 2020-11-11 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
CA2830324A1 (en) * 2011-03-31 2012-10-04 Konstanze Schafer Perfluorinated compounds for non-viral transfer of nucleic acids
DE202012013668U1 (en) 2011-06-02 2019-04-18 Raindance Technologies, Inc. enzyme quantification
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015192093A1 (en) * 2014-06-12 2015-12-17 Unger Evan C Phospholipid composition and microbubbles and emulsions formed using same
US9699301B1 (en) * 2015-05-31 2017-07-04 Emma Michaela Siritzky Methods, devices and systems supporting driving and studying without distraction
CN109908085B (en) * 2019-04-23 2021-12-03 董红燕 Respiratory tract administration medicine carrier, its preparation method and application in preparing medicine for treating heart disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2720943B1 (en) * 1994-06-09 1996-08-23 Applic Transferts Technolo Stable inverse emulsions with a high concentration of fluorinated compound (s) and their use for the pulmonary administration of medicaments and for the manufacture of multiple emulsions.

Also Published As

Publication number Publication date
AU704918B2 (en) 1999-05-06
HU9900879D0 (en) 1999-05-28
KR19990022354A (en) 1999-03-25
JPH11508237A (en) 1999-07-21
MX9709561A (en) 1998-10-31
HUP9900879A2 (en) 1999-08-30
NO975321L (en) 1998-01-27
CN1195981A (en) 1998-10-14
EP0833608A2 (en) 1998-04-08
CA2222063A1 (en) 1996-12-19
NO975321D0 (en) 1997-11-19
IL122249A0 (en) 1998-04-05
AU6153796A (en) 1996-12-30
WO1996040057A3 (en) 1997-02-20
WO1996040057A2 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
PL323931A1 (en) Compositions of reversed emulsion of fluorine derivatives of hydrocarbons for use as drug delivering carriers
HUP0001267A3 (en) Use of rapamycin derivatives for the preparation of pharmaceutical compositions treating vasculopathies
HUP9901159A3 (en) Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
PT809498E (en) PHARMACEUTICAL COMPOSITION FOR TOPIC USE CONTAINING ACICLOVIR AND HYDROCORTISONE
GR3032486T3 (en) 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol derivatives as pharmaceutical agents
HUP9901086A3 (en) Arylsulfonylaminobenzene derivatives, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
BR9609738A (en) Compositions for drug application for improved steroid stability
HU9800291D0 (en) Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus
PL327185A1 (en) Thyrosine derivatives as inhibitors of integrin-alpha v
HUP9801877A3 (en) Medicaments containing tetrahydrofuryl-sulphonamide-derivative as inhibitors of aspartyl-proteases
AP2001002270A0 (en) Metalloproteinaise inhibitors pharmaceutical compositions containing them and their pharmaceeutical uses and methods and intermediates useful for their preparation
HUP0001607A3 (en) Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds
HUP9900617A3 (en) Novel indole-, indoline- or tetrahydrokinoline derivatives as acat and lipid peroxidation inhibitors, use thereof, pharmaceutical compositions containing these compounds
HUP9901780A3 (en) Imid derivatives as phosphodiesterases and tnf inhibitors and pharmaceutical compositions containing them
AU7578696A (en) Morpholine derivatives and their use as therapeutic agents
HUP0002194A3 (en) Compositions containing prostaglandine derivatives and methods for reducing ocular hypertension
HUP9900851A3 (en) Use of benzotiophene derivatives for producing pharmaceuticals for inhibiting vascular smooth muscle cell migration
HUP9900751A3 (en) Stable pharmaceutical forms of administration containing parathormone
HUP9901326A3 (en) Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions
HUP9801993A3 (en) Ascomycin derivatives and their use for preparation of pharmaceutical compositions, process for their preparation and pharmaceutical compositions containing them
IL116539A0 (en) Compositions for transdermal delivery of acid-labile drugs
FI974442L (en) Catechol diether derivatives useful as pharmaceutical agents
ZA96452B (en) Dematological use of vitamin d derivatives
HUP9903684A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating depression
HUP0000233A3 (en) Use of pyrazolinone derivatives for producing pharmaceutical compositions useful for treating disturbances of potency